ADM (NYSE: ADM), a global leader in innovative solutions from nature, today announced that Fibersol®, a premier line of soluble prebiotic fibers, has received approval from the Therapeutic Goods Administration (TGA), part of the Australian Department of Health, for use as an active ingredient in biologicals, listed medicines, and prescription medicines. The approval expands Fibersol®’s role beyond conventional food and beverage applications into dietary supplements and other regulated health … [Read more...] about ADM’s Fibersol® approved by Therapeutic Goods Administration (TGA) as an active ingredient for health products in Australia
ADM
ADM and Asahi Group sign exclusive distribution agreement for innovative postbiotic designed to support stress, mood, and sleep
ADM (NYSE: ADM), a global leader in innovative solutions from nature, announced today its agreement with Asahi Group Foods Corporation, a leading food company headquartered in Japan, to exclusively market and distribute Asahi Group’s proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305. Backed by eight human clinical trials1,2,3,4,5,6,7,8 and capable of targeting stress, mood, and sleep support, the introduction of the postbiotic to ADM’s portfolio comes as products targeting … [Read more...] about ADM and Asahi Group sign exclusive distribution agreement for innovative postbiotic designed to support stress, mood, and sleep
ADM’s spore-forming probiotic DE111 receives approval from the Therapeutic Goods Administration (TGA) in Australia
ADM (NYSE: ADM), a global leader in innovative solutions from nature, today announced that spore-forming probiotic DE111™* (Bacillus subtilis) has received official approval from the Therapeutic Goods Administration (TGA), a part of the Australian Department of Health. This extends DE111™’s availability into new regions**, following the recent approval from the National Health Commission (NHC) in China. “This is an important milestone for ADM, as it marks the first Bacillus subtilis … [Read more...] about ADM’s spore-forming probiotic DE111 receives approval from the Therapeutic Goods Administration (TGA) in Australia
